Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03393611
Title CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

anti-thymocyte globulin + Fludarabine + Melphalan

CPX-351

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.